Topic: autism spectrum disorders

BlackThorn Therapeutics

The co-founders of autoimmune biotech Receptos are back with BlackThorn, a startup that aims to succeed in treacherous neuro territory by using physiological measures, rather than just a qualitative clinician assessment, to better define the diseases and their populations.

Axial Biotherapeutics

Axial is working to treat CNS disorders in a new way—one that doesn’t involve the blood-brain barrier. Instead, the biotech has a three-pronged approach to treat disease through the gut-brain connection.